Share on LinkedInShare on LinkedIn

ARTICLE · 13 APRIL 2020

Patent Issues Under Canada's COVID-19 Emergency Response Act

The Federal Government's COVID-19 Emergency Response Act contains certain amendments to the Patent Act that permit the Federal Government authorize anyone to "make, construct, use and...

CanadaCoronavirus (COVID-19)

The Federal Government’s COVID-19 Emergency Response Act contains certain amendments to the Patent Act that permit the Federal Government authorize anyone to “make, construct, use and sell a patented invention to the extent necessary to respond to the public health emergency”.  The government tabled and passed this Bill and it received Royal Assent on March 25, 2020.

This allows the Government to authorize the manufacture of patented medical devices – really, it applies broadly to any patented device, not just medical devices.  Any patented article that is covered by the application could be manufactured without infringing the patent rights.

The provision contemplates a type of license payment by the Government to the patent holder, which would be a dollar amount “that the Commissioner considers to be adequate remuneration in the circumstances, taking into account the economic value of the authorization and the extent to which they make, construct, use and sell

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from